Format

Send to:

Choose Destination
See comment in PubMed Commons below
Eur J Cancer. 2015 Jan;51(2):127-36. doi: 10.1016/j.ejca.2014.11.005. Epub 2014 Nov 27.

Management of sporadic desmoid-type fibromatosis: a European consensus approach based on patients' and professionals' expertise - a sarcoma patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative.

Author information

  • 1Sarcoma Unit, Interdisciplinary Tumor Center, Mannheim University Medical Center, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany. Electronic address: bernd.kasper@umm.de.
  • 2SPAEN Sarcoma Patients EuroNet e.V., Untergasse 36, 61200 Wölfersheim, Germany.
  • 3Department of Surgical Oncology, Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif Cedex, France.
  • 4Department of Radiotherapy, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
  • 5Institute of Pathology, Friedrich Alexander University Erlangen, Krankenhausstraße 12, 91054 Erlangen, Germany.
  • 6Sarcoma Unit, Interdisciplinary Tumor Center, Mannheim University Medical Center, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
  • 7SOS Desmoide, 45, rue René La Combe, 49100 Angers, France.
  • 8Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein 8, Nijmegen 6525 GA, The Netherlands.
  • 9Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, via G. Venezian 1, 20133Milan, Italy.

Abstract

Desmoid-type fibromatosis (DF) is a rare monoclonal, fibroblastic proliferation characterised by a variable and often unpredictable clinical course. It may affect nearly all parts of the body including extremities, trunk and abdomen. Considering the variable clinical presentations, anatomic locations and biological behaviours, an individualised treatment approach is required. No established or evidence-based approach for the treatment of this neoplasm is available as of today. Therefore, we propose a consensus treatment algorithm based on a round table meeting bringing together sarcoma experts from the European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) with patient advocates from Sarcoma Patients EuroNet (SPAEN). The aim of the meeting was to develop - for the first time ever - a consensus approach based on professionals' AND patients' expertise. As a fundamental prerequisite, all patients should be discussed in a multidisciplinary setting in centres or professional networks with a specific expertise in the disease.

Copyright © 2014 Elsevier Ltd. All rights reserved.

KEYWORDS:

Consensus; Desmoid-type fibromatosis; EORTC/STBSG; Patient advocacy groups; SPAEN; Treatment algorithm

PMID:
25434922
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk